Covered recipient · General Payments record
MANOELA MOTA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$4,254.53
- Reported across 203 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $395.08 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $242.13 | 18 |
| Janssen Biotech, Inc. | $29.92 | 2 |
| Daiichi Sankyo Inc. | $28.71 | 1 |
| Ardelyx, Inc. | $23.22 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.89 | 1 |
| Ipsen Biopharmaceuticals, Inc | $16.84 | 1 |
| Fresenius Kabi USA, LLC | $15.80 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.96 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073379 | CMS |
| ABBVIE INC. | $17.42 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073381 | CMS |
| ABBVIE INC. | $15.58 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073383 | CMS |
| ABBVIE INC. | $0.17 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073385 | CMS |
| ABBVIE INC. | $14.38 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073387 | CMS |
| ABBVIE INC. | $13.41 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073389 | CMS |
| ABBVIE INC. | $17.81 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073391 | CMS |
| ABBVIE INC. | $18.60 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073393 | CMS |
| ABBVIE INC. | $2.53 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073395 | CMS |
| ABBVIE INC. | $25.67 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073397 | CMS |
| ABBVIE INC. | $13.66 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073399 | CMS |
| ABBVIE INC. | $12.82 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073401 | CMS |
| ABBVIE INC. | $14.06 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073403 | CMS |
| ABBVIE INC. | $12.88 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073405 | CMS |
| ABBVIE INC. | $17.45 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073407 | CMS |
| ABBVIE INC. | $0.43 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073409 | CMS |
| ABBVIE INC. | $16.65 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073411 | CMS |
| ABBVIE INC. | $13.65 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073413 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.57 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147014898 | CMS |
| Ardelyx, Inc. | $23.22 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146696638 | CMS |
| Daiichi Sankyo Inc. | $28.71 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089459958 | CMS |
| Fresenius Kabi USA, LLC | $15.80 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146958901 | CMS |
| Ipsen Biopharmaceuticals, Inc | $16.84 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091991887 | CMS |
| Janssen Biotech, Inc. | $14.63 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078491183 | CMS |
| Janssen Biotech, Inc. | $15.29 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078490811 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.89 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137638804 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.